論文

査読有り
2020年7月1日

The Application of the in-Situ Hyperthermia Emission from Acoustic Nanodroplets for Theranostic Dual-Imaging and Antitumor Modalities.

Biological & pharmaceutical bulletin
  • Rodi Abdalkader
  • ,
  • Johan Unga
  • ,
  • Kazuo Maruyama
  • ,
  • Fumiyoshi Yamashita
  • ,
  • Mitsuru Hashida

43
7
開始ページ
1141
終了ページ
1145
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1248/bpb.b20-00171

In this study, we have developed a theranostic nanocarrier that can emit heat upon the exposure to ultrasound (US) irradiation as well as the generation of a contrast signal that can be detected with ultrasonography. The prepared acoustic nanodroplets (NDs) made with liquid perfluporopentane (PFPn) had an average size of 197.7 ± 3.6 nm in diameter and were stable in vitro for 60 min. US irradiation at 2 W.cm-2 induced phase change of NDs into bubbles in vitro. On the other hand, the intra-tumor injection of NDs in combination with US irradiation induced thermal emission in situ in B16BL6 melanoma tumor implanted into mice and the emission areas have mostly covered the tumor site. Also, the combination between NDs and US irradiation has inhibited the tumor growth. Under this condition, the heat shock protein (HSP70) in tumor was significantly upregulated after 6 h of the treatment of NDs with US. Thus, we have developed a therapeutic system with multiple theranostic modalities composed of acoustic NDs and US irradiation applicable to the tumor treatment on the external surface of the body.

リンク情報
DOI
https://doi.org/10.1248/bpb.b20-00171
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32378553
ID情報
  • DOI : 10.1248/bpb.b20-00171
  • PubMed ID : 32378553

エクスポート
BibTeX RIS